OS
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma (NCT07449949) | Eye & ENT Hospital of Fudan University | 2025-10-30 |
| Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma (NCT07450040) | Eye & ENT Hospital of Fudan University | 2024-09-12 |
| Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC (NCT05267366) | Qingdao Central Hospital | 2022-02-01 |
| Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer (NCT02629718) | Sun Yat-sen University | 2015-12-01 |
Track OS automatically
Every clearance here is in the API, with alerts when new ones post.